サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Preventive Healthcare Technologies, Products and Markets

予防医療技術、製品、市場

レポート概要

このレポートのポイント:

  • 製品、サービスにおける米国市場の予測、2008年のデータ、2009年の推定、2009−2014年および2014−2019年のCAGR(複合年間成長率)予測。
  • 早期発見、予防薬、医療過誤予防、長期ケア管理など、予防医療の概要
  • 早期発見、胎児および新生児の検査、小児の検査、男女成人の検査を含むスクリーニング装置の市場分類
  • 詳細な会社概要、特許分析

調査項目:

  • 最近数年間に実用化された、もしくは2009年時点で後期開発段階にある最も有望な予防医療技術を明らかにする。
  • 2008年におけるこれらの技術の市場規模を推定する。
  • これらの製品に対する技術的、経済的、その他の推進要因、そのほか、これらの市場で成功するための必須条件を分析する。
  • これらの技術の2014年までの市場規模を予測する。

調査の目的
この調査の目的は、予防医療への取組みに関連した市場機会を探り、特に疾患の予防に大きく貢献する可能性がある新規技術に焦点を当てて定量的分析を行います。

レポート詳細

章ごとの価格

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Title / Chapter Name Pages Price
reventive Healthcare Technologies, Products and Markets 157 $4,850
Chapter- 1: INTRODUCTION -- Complimentary 6 $0
Chapter-2: SUMMARY 2 $150
Chapter-3: OVERVIEW OF PREVENTIVE HEALTHCARE 28 $1,297
Chapter-4: MARKET ENVIRONMENT FOR PREVENTIVE HEALTHCARE 6 $278
Chapter-5: TRENDS IN THE HEALTHCARE INDUSTRY 13 $602
Chapter-6: EARLY DETECTION AND SCREENING: TECHNOLOGIES, PRODUCTS AND MARKETS, 2008--2014 27 $1,251
Chapter-7: PROPHYLAXIS: TECHNOLOGIES, PRODUCTS AND MARKETS 13 $602
Chapter-8: PREVENTING THERAPEUTIC ERRORS AND FAILURES: TECHNOLOGIES, PRODUCTS AND MARKETS 22 $1,019
Chapter-9: CHRONIC DISEASE MANAGEMENT: TECHNOLOGIES, PRODUCTS AND MARKETS 22 $1,019
Chapter-10: APPENDIX 18 $834

目次

Chapter- 1: INTRODUCTION
STUDY BACKGROUND
GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
AUTHOR’S CREDENTIALS
RELATED BCC REPORTS
BCC ONLINE SERVICES
DISCLAIMER
Chapter-2: SUMMARY
SUMMARY TABLE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, THROUGH 2014 ($ MILLIONS)
SUMMARY FIGURE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS)
Chapter-3: OVERVIEW OF PREVENTIVE HEALTHCARE
DEFINITIONS
PREVENTIVE HEALTHCARE FUNCTIONS
EARLY DETECTION
TABLE 1 U.S. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY RECOMMENDED SCREENING PROCEDURES
Personalized Screening
Automated Screening
Other New Screening Technologies
PROPHYLAXIS
PREVENTION OF ERRORS, ADVERSE EFFECTS, AND COMPLICATIONS FROM MEDICAL TREATMENT
CHRONIC DISEASE MANAGEMENT
ENABLING TECHNOLOGIES
GENOMICS/PROTEOMICS/CYTOMICS
Genomics
Proteomics
Cytomics
NANOTECHNOLOGY
Nanomaterials
Nanodevices
INFORMATION TECHNOLOGIES
Electronic Prescribing Systems
Clinical Decision Support Systems
AUTOMATION
Wireless Technologies
Sensors
Robotics
Artificial Intelligence and Decision Support
TABLE 2 APPLICATIONS OF ARTIFICIAL INTELLIGENCE TO PREVENTIVE HEALTHCARE
RFID/Barcoding
END USER SEGMENTS
HOSPITALS
PHYSICIAN PRACTICES
LONG-TERM CARE FACILITIES
MILITARY
HEALTH INSURERS
EMPLOYERS
CONSUMERS
FIGURE 1 PROJECTED U.S. POPULATION, 2008--2019 (MILLIONS)
Persons Requiring Screening and Early Detection Services
Persons Requiring Prophylaxis
TABLE 3 TARGET GROUPS FOR SELECTED VACCINES, 2008 (MILLIONS)
Persons with Chronic Illness
Hypertension
Diabetes
High Cholesterol Levels
Heart Disease
Asthma
MARKET SUMMARY
TABLE 4 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES BY FUNCTION, THROUGH 2014 ($ MILLIONS)
FIGURE 2 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES MARKET SHARES BY FUNCTION, 2008--2014 (%)
Chapter-4: MARKET ENVIRONMENT FOR PREVENTIVE HEALTHCARE
FEDERAL GOVERNMENT INITIATIVES
CENTERS FOR MEDICARE AND MEDICAID SERVICES
Medicare
Medicaid
SCHIP
OTHER FEDERAL PREVENTIVE-CARE PROGRAMS
Immunization Grant (Section 317) Program
National Breast and Cervical Cancer Early Detection Program
PROPOSED U.S. HEALTHCARE SYSTEM RESTRUCTURING
RELATED FEDERAL INITIATIVES
ETHICAL CONCERNS
Chapter-5: TRENDS IN THE HEALTHCARE INDUSTRY
RISING HEALTHCARE COSTS
FIGURE 3 TOTAL U.S. HEALTHCARE EXPENDITURES, 1968--2008 ($ BILLIONS IN 2008 DOLLARS)
FIGURE 4 PER-CAPITA U.S. HEALTHCARE EXPENDITURES, 1968--2008 ($ BILLIONS IN 2008 DOLLARS)
FIGURE 5 U.S. HEALTHCARE EXPENDITURES AS A PERCENTAGE OF REAL GDP, 1968 AND 2008 (2008 $ BILLIONS)
PREVENTIVE HEALTHCARE AND OVERALL MEDICAL EXPENDITURES
FIGURE 6 U.S. EXPENDITURES ON PREVENTIVE VS. OTHER TYPES OF HEALTHCARE, 2008 ($ BILLIONS)
HEALTH INSURANCE COVERAGE AND REIMBURSEMENT
MEDICAL EDUCATION
HEALTHCARE PROFESSIONALS’ ATTITUDES
PATIENT ATTITUDES
ECONOMIC ENVIRONMENT
EMPLOYMENT TRENDS
FIGURE 7 TRENDS IN U.S. NON-FARM PAYROLL EMPLOYMENT (000 WORKERS)
IMPACT OF ECONOMIC TRENDS ON EMPLOYER HEALTH COVERAGE
FIGURE 8 TRENDS IN EMPLOYER-SPONSORED HEALTH INSURANCE, 2000--2008 (PERCENT OF U.S. COMPANIES OFFERING HEALTH INSURANCE)
Chapter-6: EARLY DETECTION AND SCREENING: TECHNOLOGIES, PRODUCTS AND MARKETS, 2008--2014
SUMMARY
FIGURE 9 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTON TECHNOLOGIES, 2008--2014 ($ MILLIONS)
TECHNOLOGIES AND PRODUCTS
PERSONALIZED MEDICINE
Genetic Testing
Suppliers of Genetic Tests
TABLE 5 SUPPLIERS OF GENETIC TESTS
Proteomic Tests
Suppliers of Proteomic Tests
TABLE 6 SUPPLIERS OF PROTEOMIC TESTS
AUTOMATED SCREENING
Telehealth Kiosks
Suppliers of Telehealth Kiosks
TABLE 7 SUPPLIERS OF TELEHEALTH KIOSKS
Eye Health Kiosks
Automated Drug Testing
Suppliers of Automated Drug Testing Equipment
TABLE 8 DEVELOPERS AND SUPPLIERS OF AUTOMATED DRUG TESTING EQUIPMENT
OTHER ADVANCED SCREENING TESTS
Breast Cancer Screening
Molecular Breast Imaging
Automated Whole Breast Ultrasound
CT Colonography
Automated Skin Cancer Screening
Suppliers
TABLE 9 DEVELOPERS AND SUPPLIERS OF OTHER ADVANCED HEALTH SCREENING TECHNOLOGIES
MARKETS
SUMMARY
TABLE 10 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTION TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
FIGURE 10 EARLY DETECTION AND SCREENING PRODUCT SEGMENTS, 2008-2014 (%)
PERSONALIZED MEDICINE
TABLE 11 U.S. MARKET FOR PERSONALIZED PREVENTIVE MEDICINE ($ MILLIONS)
Genetic Screening
FIGURE 11 U.S. GENETIC TESTING MARKET SHARES, 2008 (%)
TABLE 12 U.S. MARKET FOR GENETIC SCREENING TESTS ($ MILLIONS)
Proteomic Screening
TABLE 13 U.S. MARKET FOR PROTEOMIC SCREENING TESTS ($ MILLIONS)
AUTOMATED SCREENING
TABLE 14 U.S. MARKET FOR AUTOMATED HEALTH ASSESSMENT AND SCREENING SYSTEMS BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS)
Telehealth Kiosks
TABLE 15 NEW TELEHEALTH KIOSK SALES AND LEASE REVENUES, 2014 (UNITS/$)
Eye Health Kiosks
TABLE 16 U.S. MARKET FOR AUTOMATED EYE HEALTH KIOSKS, THROUGH 2014 ($ MILLIONS)
Automated Drug Testing
FIGURE 12 AUTOMATED TEST EQUIPMENT SHARE OF DRUG TESTING MARKET, 2008 (%)
FIGURE 13 DRUGS OF ABUSE VS. THERAPEUTIC DRUG TESTING SHARES OF AUTOMATED DRUG TESTING EQUIPMENT MARKET, 2008 (%)
TABLE 17 U.S. MARKET FOR AUTOMATED DRUG TESTING SYSTEMS, THROUGH 2014 ($ MILLIONS)
OTHER ADVANCED SCREENING AND EARLY DETECTION TECHNOLOGIES
TABLE 18 U.S. MARKET FOR OTHER ADVANCED SCREENING TECHNOLOGIES BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS)
BREAST CANCER SCREENING
TABLE 19 U.S. MARKET FOR ADVANCED BREAST CANCER SCREENING SYSTEMS, THROUGH 2014 ($ MILLIONS)
Molecular Breast Imaging
TABLE 20 U.S. MARKET FOR MOLECULAR BREAST IMAGING SYSTEMS, THROUGH 2014 ($ MILLIONS)
ABUS
TABLE 21 U.S. MARKET FOR AUTOMATED WHOLE BREAST ULTRASOUND SYSTEMS, THROUGH 2014 ($ MILLIONS)
CT COLONOGRAPHY
TABLE 22 U.S. MARKET FOR CT COLONOGRAPHY, THROUGH 2014 ($ MILLIONS)
AUTOMATED SKIN CANCER DETECTION
TABLE 23 U.S. MARKET FOR AUTOMATED SKIN CANCER DETECTION SYSTEMS, THROUGH 2014 ($ MILLIONS)
Chapter-7: PROPHYLAXIS: TECHNOLOGIES, PRODUCTS AND MARKETS
SUMMARY
FIGURE 14 U.S. MARKET FOR NEW VACCINES, 2008--2014 ($ MILLIONS)
TECHNOLOGIES
FLU VACCINES
Bird Flu Vaccine
Swine Flu Vaccine
MENINGOCOCCAL VACCINES
COMBINED TETANUS-DIPHTHERIA-PERTUSSIS VACCINES
HUMAN PAPILLOMA VIRUS VACCINE
OTHER NEW VACCINES
MMR/Varicella Vaccine
Rotavirus Vaccines
Shingles Vaccine
MARKETS
SUMMARY
FIGURE 15 U.S. MARKET FOR NEW HUMAN VACCINES, 2008 (%)
TABLE 24 U.S. MARKET FOR NEW VACCINES, THROUGH 2014 ($ MILLIONS)
FLU VACCINES
TABLE 25 U.S. PURCHASES OF NOVEL FLU VACCINES, THROUGH 2014 ($ MILLIONS)
MENINGOCOCCAL VACCINES
TABLE 26 U.S. MARKET FOR MENINGOCOCCAL VACCINES, THROUGH 2014 ($ MILLIONS)
TDAP VACCINES
TABLE 27 U.S. MARKET FOR TDAP VACCINES, THROUGH 2014 ($ MILLIONS)
HPV VACCINES
TABLE 28 U.S. MARKET FOR HPV VACCINES, THROUGH 2014 ($ MILLIONS)
OTHER NEW VACCINES
MMR/Varicella
TABLE 29 U.S. MARKET FOR OTHER NEW VACCINES, THROUGH 2014 ($ MILLIONS)
Rotavirus
Shingles
Chapter-8: PREVENTING THERAPEUTIC ERRORS AND FAILURES: TECHNOLOGIES, PRODUCTS AND MARKETS
SUMMARY
FIGURE 16 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008--2014 ($ MILLIONS)
TECHNOLOGIES
CLINICAL DECISION AIDS AND OTHER INFORMATION TECHNOLOGIES
Electronic Prescribing
Software
Mobile Interface Devices
Electronic Data Interchange
TABLE 30 E-PRESCRIPTION SOFTWARE VENDORS
Computerized Provider Order Entry Systems
TABLE 31 CPOE TECHNOLOGY VENDORS
Clinical Decision Support Systems
TABLE 32 CLINICAL DECISION SUPPORT TECHNOLOGY VENDORS
MEDICATION FORMULATION, DISPENSING, AND PACKAGING SYSTEMS
Automated Prescription Formulation/Dispensing Systems
Packaging Machines
Tablet Counters
Unit-Dose or Blister Pack Repackaging and Dispensing Systems
Intravenous Compounders
Dispensing Systems
Centralized Dispensing Systems
Automated Medication Carts
Decentralized Dispensing Devices
Smart Infusion Pumps
TABLE 33 SUPPLIERS OF AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS
Packaging
Bottle Cap Medication Reminder
Medication Label Reader for the Visually Impaired
MARKETS
SUMMARY
TABLE 34 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
FIGURE 17 THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008--2014 (%)
ELECTRONIC PRESCRIBING
TABLE 35 U.S. MARKET FOR ELECTRONIC PRESCRIBING TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
FIGURE 18 U.S. ELECTRONIC PRESCRIPTION MARKET SEGMENTS (%)
COMPUTERIZED PROVIDER ORDER ENTRY
TABLE 36 NUMBER OF U.S. HOSPITALS WITH COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2007
TABLE 37 U.S. MARKET FOR COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2014 ($ MILLIONS)
COMPUTERIZED DECISION SUPPORT
TABLE 38 U.S. MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, THROUGH 2014 ($ MILLIONS)
AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING
TABLE 39 U.S. MARKET FOR HOSPITAL/INPATIENT AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS, THROUGH 2014 ($ MILLIONS)
SMART INFUSION PUMPS
TABLE 40 U.S. MARKET FOR SMART INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
SMART PACKAGING
TABLE 41 U.S. MARKET FOR SMART PACKAGING TO PREVENT MEDICATION ERRORS, THROUGH 2014 ($ MILLIONS)
Chapter-9: CHRONIC DISEASE MANAGEMENT: TECHNOLOGIES, PRODUCTS AND MARKETS
SUMMARY
FIGURE 19 U.S. MARKET FOR ADVANCED CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS)
TECHNOLOGIES
MONITORING
Blood Pressure Monitors
Glucose Monitors
Cholesterol Monitors
Cardiac Monitors
Asthma Monitors
Pervasive Monitoring
Embedded Monitors
Wearable Monitors
Wireless Telemetry
Cellular Networks
Bluetooth
Other Technologies
Suppliers
TABLE 42 SUPPLIERS OF ADVANCED TECHNOLOGIES FOR MONITORING CHRONIC DISEASES
THERAPEUTIC DEVICES
Insulin Administration Devices
Insulin Pumps
Insulin Inhalers
Suppliers
TABLE 43 SUPPLIERS OF ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASES
COMMERCIAL CHRONIC DISEASE MANAGEMENT SERVICES
Suppliers
TABLE 44 CHRONIC DISEASE MANAGEMENT ORGANIZATIONS
MARKETS
SUMMARY
TABLE 45 MARKET FOR CHRONIC DISEASE MANAGEMENT TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
FIGURE 20 CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES MARKET SHARES, 2008-2014 (%)
MONITORING
TABLE 46 MARKET FOR ADVANCED MONITORING TECHNOLOGIES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS)
Advanced Sensors
TABLE 47 U.S. MARKET FOR ADVANCED NONINVASIVE SENSORS, THROUGH 2014 ($ MILLIONS)
Pervasive Monitoring
TABLE 48 HOME MONITORING AND TELEMETRY SALES, THROUGH 2014 ($ MILLIONS)
Telemetry
TABLE 49 SALES OF HOME TELEMETRY MONITORS, THROUGH 2014 ($ MILLIONS)
THERAPEUTIC DEVICES
TABLE 50 MARKET FOR ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS)
Insulin Pumps
TABLE 51 MARKET FOR INSULIN PUMPS, THROUGH 2014 ($ MILLIONS)
TABLE 52 INSULIN PUMP SALES, THROUGH 2014 (NUMBER OF PUMPS/$ MILLION)
Insulin Inhalers
TABLE 53 MARKET FOR INSULIN INHALERS, THROUGH 2014 ($ MILLIONS)
DISEASE MANAGEMENT SERVICES
TABLE 54 MARKET FOR COMMERCIAL DM SERVICES, THROUGH 2014 ($ MILLIONS)
Chapter-10: APPENDIX
APPENDIX A: COMPANY PROFILES
EARLY DETECTION AND SCREENING
COMPUTERIZED SCREENING INC.
CORRELOGIC SYSTEMS, INC.
DILON TECHNOLOGIES
GAMMA MEDICA-IDEAS, INC.
ICAD INC.
MYRIAD GENETICS, INC.
NOVX SYSTEMS INC.
POLARTECHNICS LTD.
STREETIME TECHNOLOGIES
U-SYSTEMS, INC.
VERMILLION, INC.
VIATRONIX, INC.
PROPHYLAXIS
MERCK & CO., INC.
ERROR PREVENTION
BAXA CORP.
DRFIRST.COM
LIFECOM, INC.
MASSACHUSETTS GENERAL HOSPITAL
OMNICELL, INC.
SCRIPTPRO
SIGMA INTERNATIONAL GENERAL MEDICAL APPARATUS LLC
SURESCRIPTS LLC
THERADOC INC.
CHRONIC DISEASE MANAGEMENT
ALERE
CARD GUARD AG
ECHO THERAPEUTICS, INC.
HEALTH FRONTIER, INC.
HEALTHWAYS, INC.
MANNKIND CORP.
MEDTRONIC MINIMED INC.
MICRODOSE THERAPEUTX, INC.
OMRON HEALTHCARE, INC.
PFIZER INC.
PREMD INC.
T+ MEDICAL AMERICAS
U.S. PREVENTIVE MEDICINE
VECTURA GROUP PLC
VIVOMETRICS INC.
APPENDIX B: PATENT ANALYSIS
FIGURE 21 U.S. PATENTS RELATED TO NEW PREVENTIVE HEALTHCARE TECHNOLOGIES (%)

発刊日

2009/10/01

体裁

PDF / 157ページ

販売価格

4,850USD

発行

BCC Research

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます

関連カテゴリ

医薬品産業(医療制度、医療観光など) / 医薬品産業(医療制度、医療観光など)

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE